Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Nov;19(10):1210-8.
doi: 10.1080/09540120701426516.

Reasons for ART non-adherence in the Deep South: adherence needs of a sample of HIV-positive patients in Mississippi

Affiliations

Reasons for ART non-adherence in the Deep South: adherence needs of a sample of HIV-positive patients in Mississippi

K Rivet Amico et al. AIDS Care. 2007 Nov.

Abstract

HIV prevalence in the American Deep South has reached crisis proportions and greater numbers of patients are enrolling in clinical care and beginning antiretroviral therapy (ART). In order to gain maximum benefit from ART, patients must sustain high levels of adherence to demanding regimens over extended periods of time. Many patients are unable to maintain high rates of adherence and may need assistance to do so, which may be based upon an understanding of barriers to adherence for a given population. The current study sought to gain understanding of barriers to adherence for a mixed urban/rural HIV-positive patient population in Mississippi and to determine whether barriers to adherence may be specific to gender, employment, depressive symptoms or educational attainment status. Seventy-two patients who missed a dose of ART medication over the last three days endorsed the top five reasons for missing a dose as: (1) not having the medication with them, (2) sleeping through the dose time, (3) running out of the medication, (4) being busy with other things and (5) other. Reported barriers were fairly consistent across different groups, although women and those classified as having moderate to severe depressive symptoms reported different patterns of adherence barriers. Results suggest that adherence interventions implemented in the Deep South must take into account specific barriers faced by individuals within this region, where stigma, gender disparities and limited resources are prevalent.

PubMed Disclaimer

References

    1. Arnsten J, Demas P, Gourevitch M, Buono D, Farzadegan H, Schoenbaum E. Adherence and viral load in HIV-infected drug users: Comparison of self-report and Medication Event Monitors (MEMS). Presented at The 7th Conference on Retroviruses and Opportunistic Infections; January 30–February 2, 2000; San Francisco, CA. 2000.
    1. Bangsberg DR, Moss AR, Deeks SG. Paradoxes of adherence and drug resistance to HIV antiretroviral therapy. Journal of Antimicrobial Chemotherapy. 2004;5:696–699. - PubMed
    1. Berg KM, Demas PA, Howard AA, Schoenbaum EE, Gourevitch MN, Arnsten JH. Gender differences in factors associated with adherence to antiretroviral therapy. Journal of General Internal Medicine. 2004;19:1111–1117. - PMC - PubMed
    1. Boyle B. What do patients mean when they say that they forget to take their HAART. Presented at The 15th International AIDS Conference; July 11–16, 2004; Bangkok, Thailand. 2004. [(accessed June 15, 2006)]. Available at: www.hivandhepatitis.com/2004icr/aids2004.
    1. Burrack JH, Barrett DC, Stall RD, Chesney MA, Ekstrand ML, Coates TJ. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. Journal of the American Medical Association. 1993;270:2568–2573. - PubMed

Publication types

Substances